Knowledge graph · Variant
ABL1 F317L
SNV
- Identifier
- CI-VAR-00001105
- Entity page
- /variant/abl1-f317l ↗
- Edges
- 12
- Neighbours
- 2 cancers8 drugs
- Drawn
- 10 of 10 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,147Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| ABL1 F317L predicts response to …PREDICTS_RESPONSE_TO12 of 10 | ||||||||
| → predicts response to | Dasatinibsmall_molecule 3 source records aggregated | resistance | B | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 3 | Curated | civic | graph → |
| → predicts response to | Imatinib Mesylatesmall_molecule 2 source records aggregated | |||||||